Interestingly, inhibiting DDX21-mediated RG4-dependent translation of MAGED2 correlates with an increase in TRAIL-R2 expression and a sensitization of breast cancer cells to TRAIL-mediated apoptosis. Here, TNFSF10 is linked to breast cancer.